Bivins B A, Rapp R P, DeLuca P P, McKean H, Griffen W O
Surgery. 1979 Apr;85(4):388-94.
Infusion phlebitis is the most common complication of intravenous therapy. Six methods of reducing the incidence of infusion phlebitis including inline final filtration, buffers, heparin, hydrocortisone, heparin-hydrocortisone combinations, and frequent set changes were tested in a two part randomized prospective double-blind study of 266 surgical patients. Patients who received filtered fluids had a significantly decreased incidence of infusion phlebitis as compared with that of controls (P = 0.0000001). Of the other methods tested, only the heparin-hydrocortisone combinations achieved any significant decrease in phlebitis (P less than 0.5). Therefore, inline filtration is a highly effective means of decreasing the incidence of infusion phlebitis and should be considered as a routine part of intravenous therapy.
输液性静脉炎是静脉治疗最常见的并发症。在一项针对266例外科手术患者的两部分随机前瞻性双盲研究中,测试了六种降低输液性静脉炎发生率的方法,包括在线终端过滤、缓冲液、肝素、氢化可的松、肝素-氢化可的松组合以及频繁更换输液装置。与对照组相比,接受过滤液的患者输液性静脉炎的发生率显著降低(P = 0.0000001)。在测试的其他方法中,只有肝素-氢化可的松组合使静脉炎有任何显著降低(P小于0.5)。因此,在线过滤是降低输液性静脉炎发生率的一种高效方法,应被视为静脉治疗的常规组成部分。